NCHR’s Comments on FDA’s Draft Guidance on Levonorgestrel

March 23, 2020 National Center for Health Research’s Public Comments on FDA’s Draft Guidance on Levonorgestrel [Docket Number FDA-2007-D-0369] We are pleased to have the opportunity to comment on the FDA Draft Guidance on Levonorgestrel IUD devices for the design of bioequivalence studies supporting abbreviated new drug applications.  The National Center for Health Research (NCHR) is […]

Read More »